MainOSEL conducts laboratory and field research in the areas of physical, life, and engineering sciences as it relates to the effects of medical devices on human health. This measure intends to monitor the progression of OSEL’s research projects by establishing milestone goals and tracking timely completion of these milestones.(1) Measure was implemented April 1, 2010.Percentline0100Target

FY 2010 Overall: 89%

Apr 20107591May 20107579Jun 20107583Jul 201075100Aug 20107588Sep 201075940100Target

FY 2011 Overall: 84%

Oct 20107580Nov 20107574Dec 20107577Jan 20117586Feb 20117583Mar 20117584Apr 20117587May 20117584Jun 20117590Jul 20117589Aug 20117589Sep 20117586SubPercent of actions listed in OSEL research plans completed on time during the month (1)Numbercolumn060Target

FY 2010 Total: 103

Apr 201030May 201015Jun 201015Jul 201012Aug 201014Sep 201017060Target

FY 2011 Total: 368

Oct 201032Nov 201026Dec 201040Jan 201130Feb 201125Mar 201138Apr 201126May 201127Jun 201138Jul 201125Aug 201131Sep 201130SubPercent of actions listed in OSEL research plans completed on time during the month (1)Numbercolumn0Target

FY 2010 Total: 116

Apr 201033May 201019Jun 201018Jul 201012Aug 201016Sep 201018Target

FY 2011 Total: 439

Oct 201040Nov 201035Dec 201052Jan 201135Feb 201130Mar 201145Apr 201130May 201132Jun 201142Jul 201128Aug 201135Sep 201135MainNumbercolumn0Target

Apr 201057May 201057Jun 201057Jul 201057Aug 201057Sep 201057Target

Oct 201057Nov 201057Dec 201057Jan 201157Feb 201157Mar 201157Apr 201157May 201157Jun 201157Jul 201157Aug 201157Sep 201157http://www.fda.gov/AboutFDA/Transparency/track/ucm203038.htmFDA-TRACK CDRH Dashboard਍††਍਍